Contribution: Industrial Research Assistance Program – Contributions to Firms
Allarta Life Science Inc.
$75,000.00
Developing Robust Immune-Evasive Hydrogel Capsules for Cell Therapy
EF 2021-22 · 2021-10-01
Résumé
Cell-based therapies for chronic disorders such as Type 1 Diabetes hold the promise of curative treatments. This project aims to developing robust yet immune-evasive hydrogel capsules to enable islet transplants in a mouse model.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Dundas|Dundas, Ontario, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
735566085
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2022-03-31
Agreement Number
981387
Agreement Start Date
2021-10-01
Agreement Title
Developing Robust Immune-Evasive Hydrogel Capsules for Cell Therapy
Agreement Title (French)
Mise au point de capsules d'hydrogel robustes et immunologiques pour la thérapie cellulaire
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Cell-based therapies for chronic disorders such as Type 1 Diabetes hold the promise of curative treatments. This project aims to developing robust yet immune-evasive hydrogel capsules to enable islet transplants in a mouse model.
Description (French)
Les thérapies cellulaires pour les troubles chroniques tels que le diabète de type 1 sont la promesse de traitements curatifs. Ce projet vise à mettre au point des capsules d'hydrogel robustes, mais non immunologiques, pour permettre les greffes d'îlots dans un modèle de souris.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Hamilton West--Ancaster--Dundas
Federal Riding (French)
Hamilton-Ouest--Ancaster--Dundas
Federal Riding Number
35038
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
735566085
Recipient City
Dundas|Dundas
Recipient Country
CA
Recipient Legal Name
Allarta Life Science Inc.
Recipient Operating Name
Allarta
Recipient Postal Code
L9H 2E7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q3-981387
